**2.6 Case report Fiona**

**Focus:** insulin pump implementation can result in subjective improvement, without effect in laboratory parameters.

**History:** The first signs of T1D appeared in 2014 so Fiona (today 48 y/o) was treated with an insulin pen for 15 months. The HbA1c concentration has been increasing during this treatment, thus the insulin pump MiniMed 640G was implemented and she was trained in selfmonitoring on glucometer-strips system Contour (**Figure 14**). Up until the beginning of the year 2017, her clinical and laboratory findings were improving. Since then, her HbA1c concentration has been increasing (**Table 6**, **Figures 15** and **16**). The reason for this rise is multifactorial: difficult life situations, struggling to keep a constant regime of glycemia monitoring, etc. Fiona is satisfied with the insulin pump as it improved the quality of her everyday life; she does not need to prick herself a few times per day as she works on shifts. Fiona is not convinced to use CGM, although she is aware of insufficient compensation and low frequency of self-monitoring: two times per day, sometimes only once a week.

**Figure 14.** *Glucometer Contour plus one showing glycaemia 4.3 mmol/l. Box with test strips (on the right).*


### **Table 6.**

*Fiona's clinical and laboratory parameters from T1D start over 8 years.*

*Benefits of Implementation of Insulin Pump in People with Type 1 Diabetes: 10 Case Reports DOI: http://dx.doi.org/10.5772/intechopen.110073*
